N/A N=72 Randomized Quadruple-blind Treatment

Treatment of Androgenetic Alopecia in Females, 9 Beam

Androgenetic Alopecia · Hair Loss · Female Pattern Baldness

Bottom Line

View on ClinicalTrials.gov: NCT00981461 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2012

Primary outcome: Primary: Changes in Terminal Hair Count Week 16 and 26 Weeks Over Baseline — 1.3; 14.8; 2.8; 20.2 hairs per cm^2

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: HairMax LaserComb (Device); Control Device (Device)
Age: Adult · 25+ yrs
Sex: Female
Sponsor: Lexington International, LLC
Primary completion: Oct 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Changes in Terminal Hair Count Week 16 and 26 Weeks Over Baseline	1.3; 14.8; 2.8; 20.2	—

Summary

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 9 beam model in promoting hair growth in females diagnosed with androgenetic alopecia when treatment is applied as directed.

Eligibility Criteria

Inclusion Criteria

Diagnosis of androgenetic alopecia
Fitzpatrick Skin Types I-IV
Ludwig I-4, II-1, II-2, or frontal
Active hair loss within last 12 months

Exclusion Criteria

Photosensitivity to laser light
Malignancy in the target area
Pregnancy
Lactating females

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00981461). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.